Mutagonda Ritah F, Bwire George, Sangeda Raphael Zozimus, Kilonzi Manase, Mlyuka Hamu, Ndunguru Joyce, Jonathan Agnes, Makani Julie, Minja Irene Kida, Ruggajo Paschal, Balandya Emmanuel, Kamuhabwa Appolinary A R
Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania.
Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania.
Infect Drug Resist. 2022 Aug 10;15:4407-4418. doi: 10.2147/IDR.S367873. eCollection 2022.
Bacterial infections contribute significantly to morbidity and mortality in sickle cell disease (SCD) patients, particularly children under five years of age. In Tanzania, prophylaxis against pneumococcal infection among children with SCD advocates the use of both oral penicillin V (PV) and pneumococcal vaccines (PNV). Therefore, this study aimed to investigate nasopharyngeal carriage and antibiogram of () and () in children with SCD in Tanzania.
This cross-sectional study was undertaken at the two Sickle Pan-African Research Consortium (SPARCO) study sites in Dar es salaam, Tanzania. The study was conducted for six months and enrolled children with SCD between the ages of 6 to 59-months. A semi-structured questionnaire was used to collect patient data. Nasopharyngeal swabs were collected from all participants and cultured for and other bacterial isolates. Antimicrobial susceptibility tests of the isolates were done using the disc diffusion method.
Out of 204 participants, the overall prevalence of bacterial carriage was 53.4%, with (23.5%), coagulase-negative Staphylococci (CoNS) (23%) and (7.8%) being commonly isolated. In antibiotic susceptibility testing, isolates were most resistant to penicillin (81.8%), whereas 81.3% of S. pneumoniae isolates were resistant to co-trimoxazole. The least antimicrobial resistance was observed for chloramphenicol for both and isolates (6.3% versus 0%). The proportion of multi-drug resistance (MDR) was 66.7% for isolates and 25% for isolates.
There are substantially high nasopharyngeal carriage pathogenic bacteria in children with SCD in Dar es Salaam, Tanzania. The presence of MDR strains to the commonly used antibiotics suggests the need to reconsider optimizing antimicrobial prophylaxis in children with SCD and advocacy on pneumococcal vaccines.
细菌感染在镰状细胞病(SCD)患者,尤其是五岁以下儿童的发病和死亡中起重要作用。在坦桑尼亚,对SCD儿童预防肺炎球菌感染提倡同时使用口服青霉素V(PV)和肺炎球菌疫苗(PNV)。因此,本研究旨在调查坦桑尼亚SCD儿童中()和()的鼻咽部携带情况及抗菌谱。
本横断面研究在坦桑尼亚达累斯萨拉姆的两个镰状细胞泛非研究联盟(SPARCO)研究地点进行。该研究持续了六个月,纳入了6至59个月大的SCD儿童。使用半结构化问卷收集患者数据。从所有参与者中采集鼻咽拭子,培养()和其他细菌分离株。分离株的药敏试验采用纸片扩散法进行。
在204名参与者中,细菌携带的总体患病率为53.4%,常见分离菌为(23.5%)、凝固酶阴性葡萄球菌(CoNS)(23%)和(7.8%)。在药敏试验中,()分离株对青霉素的耐药性最高(81.8%),而81.3%的肺炎链球菌分离株对复方新诺明耐药。对于()和()分离株,氯霉素的耐药性最低(分别为6.3%和0%)。()分离株的多重耐药(MDR)比例为66.7%,()分离株为25%。
在坦桑尼亚达累斯萨拉姆,SCD儿童鼻咽部携带病原菌的情况相当严重。对常用抗生素存在MDR菌株表明,有必要重新考虑优化SCD儿童的抗菌预防措施,并提倡使用肺炎球菌疫苗。